Topics
Innovation
Laser
Medical
Practice
Research
Surgical
Training
Projecting changes in the management of glaucoma.
View Issue
Editorially independent content supported by Alcon, Allergan, Dompé, Johnson & Johnson, and Zeiss
View Insert
Editorially independent content, supported with advertising from: Avellino, Johnson & Johnson Vision, New World Medical, Nova Eye Medical, and Zeiss
In This Issue
Iqbal Ike K. Ahmed, MD, FRCSC
Surgeons revisit a case they commented on last year.
Jacob Brubaker, MD; Sahar Bedrood, MD, PhD; and Xiongfei Liu, MD
Antifibrotic medicines may improve success rates with the Ahmed Glaucoma Valve.
Arash Davanian, DO, and Rachel W. Kuchtey, MD, PhD
The first in a two-part series on this multifactorial disease subtype.
Arpine Barsegian, MD
Translating patient preferences into actionable insights.
Richie Kahn, MPH
Which practices are most sustainable for addressing unmet needs and empowering local ophthalmologists?
Ivo Ferreira, MD; Malik Y. Kahook, MD; Jason Penniecook, MD; Jeff Pettey, MD, MBA; and Oluwatosin Smith, MD
A new paradigm for the diagnostic evaluation of glaucoma.
Christopher K.S. Leung, MD, MB ChB
Tips for navigating this learning curve.
Inas Gadelkarim, MD, FRCOphth, FRCS
Expanding access to and delivery of SLT poses a great challenge.
Nathan M. Radcliffe, MD
The COVID-19 pandemic necessitated new solutions and policies, but what does the future hold for virtual care?
Susan Liang, MD
Newer models can help to identify and forecast worsening glaucoma.
Jithin Yohannan, MD, MPH
Sustained-release treatment options are filling an unmet need.
Courtney L. Ondeck, MD, MPhil
How has practice changed, and what lies ahead?
Cathleen McCabe, MD, and Sara Rapuano, MBA, CPC, COE, OCS
A high turnover rate and certification requirements are contributing to the shortage.
Mitzi P. Thomas, COMT, BPS
Subscribe
Stay up to date all on all things Glaucoma by signing up to receive our print publication or subscribe to our email alerts.